$WTER
ALKALINE WATER Co INC Stock $wter

$wter Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000106299323016652 Filed on August 17, 2023

Income Statement

Concept	2023 Q3	2023 Q1	2023
Revenue		$12.50M	$63.78M
YoY Change		-22.44%	5.25%
Cost Of Revenue		$11.84M	$52.13M
YoY Change		-25.32%	14.88%
Gross Profit		$664.9K	$11.65M
YoY Change		146.44%	-23.48%
Gross Profit Margin		5.32%	18.26%
Selling, General & Admin		$7.771M	$33.68M
YoY Change		-28.16%	-37.88%
% of Gross Profit		1168.83%	289.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$290.0K	$900.1K
YoY Change		-10.6%	12.32%
% of Gross Profit		43.61%	7.73%
Operating Expenses		$7.771M	$33.68M
YoY Change		-28.16%	-37.89%
Operating Profit		-$7.106M	-$22.03M
YoY Change		-32.63%	-43.51%
Interest Expense		-$421.8K	$2.971M
YoY Change		-15.04%	-423.94%
% of Operating Profit
Other Income/Expense, Net			-$5.376M
YoY Change			816.73%
Pretax Income		-$7.528M	-$27.41M
YoY Change		-31.84%	-30.77%
Income Tax
% Of Pretax Income
Net Earnings		-$7.528M	-$27.41M
YoY Change		-31.84%	-30.77%
Net Earnings / Revenue		-60.23%	-42.97%
Basic Earnings Per Share			-$2.99
Diluted Earnings Per Share		-$0.76	-$2.99
COMMON SHARES
Basic Shares Outstanding	10.40M shares	148.0M shares	9.162M shares
Diluted Shares Outstanding			9.162M shares

Balance Sheet

Concept	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.039M	$1.039M
YoY Change	-32.15%	-32.15%
Cash & Equivalents	$1.039M
Short-Term Investments
Other Short-Term Assets	$2.801M	$2.801M
YoY Change	-10.09%	-10.09%
Inventory	$5.591M	$5.591M
Prepaid Expenses
Receivables	$6.520M	$6.520M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$15.95M	$15.95M
YoY Change	-24.6%	-24.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.058M	$2.078M
YoY Change	71.4%	54.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.078M	$2.078M
YoY Change	54.74%	54.74%
TOTAL ASSETS
Total Short-Term Assets	$15.95M	$15.95M
Total Long-Term Assets	$2.078M	$2.078M
Total Assets	$18.03M	$18.03M
YoY Change	-19.87%	-19.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.62M	$11.62M
YoY Change	11.25%	11.25%
Accrued Expenses	$1.996M	$2.133M
YoY Change	-1.98%	-3.56%
Deferred Revenue
YoY Change
Short-Term Debt	$9.596M	$9.596M
YoY Change	3.54%	3.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.34M	$23.34M
YoY Change	6.5%	6.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$22.22K	$22.22K
YoY Change	-87.57%	-87.57%
Total Long-Term Liabilities	$22.22K	$22.22K
YoY Change	-87.57%	-87.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.34M	$23.34M
Total Long-Term Liabilities	$22.22K	$22.22K
Total Liabilities	$23.37M	$23.37M
YoY Change	5.73%	5.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$137.1M
YoY Change	25.17%
Common Stock	$10.01K
YoY Change	-90.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.337M	-$5.337M
YoY Change
Total Liabilities & Shareholders Equity	$18.03M	$18.03M
YoY Change	-19.87%	-19.87%

Cashflow Statement

Concept	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$7.528M	-$27.41M
YoY Change	-31.84%	-30.77%
Depreciation, Depletion And Amortization	$290.0K	$900.1K
YoY Change	-10.6%	12.32%
Cash From Operating Activities	-$509.4K	-$10.43M
YoY Change	-91.34%	-67.22%
INVESTING ACTIVITIES
Capital Expenditures	$656.8K	$1.445M
YoY Change	-231.71%	-245.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$656.8K	-$1.445M
YoY Change	31.71%	45.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.269M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.13K	$11.38M
YoY Change	-99.74%	-54.86%
NET CHANGE
Cash From Operating Activities	-509.4K	-$10.43M
Cash From Investing Activities	-656.8K	-$1.445M
Cash From Financing Activities	12.13K	$11.38M
Net Change In Cash	-1.154M	-$492.3K
YoY Change	-34.51%	-93.52%
FREE CASH FLOW
Cash From Operating Activities	-$509.4K	-$10.43M
Capital Expenditures	$656.8K	$1.445M
Free Cash Flow	-$1.166M	-$11.87M
YoY Change	-78.33%	-61.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5268592	usd
CY2023	wter	Stock Issued During Period Value In Connection With Convertible Note StockIssuedDuringPeriodValueInConnectionWithConvertibleNote	6275573	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	23.1
CY2023	wter	Stock Issued During Period Warrant Exercises StockIssuedDuringPeriodWarrantExercises	5653544	usd
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-27405193	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3382518	usd
CY2022	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredForfeitedWeightedAverageRemainingContractualTerm	P8Y4M24D
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1598855	usd
CY2023	dei	Document Type DocumentType	10-K
CY2022	wter	Non Cash Lease Expense NonCashLeaseExpense	6840	usd
CY2023Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	0	usd
CY2021Q2	wter	Stock Issued During Period Shares Stock Options Exercised Under Cashless Exercise Plan StockIssuedDuringPeriodSharesStockOptionsExercisedUnderCashlessExercisePlan	48230	usd
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8541 E. Anderson Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85255
CY2023	dei	City Area Code CityAreaCode	480
CY2023	dei	Local Phone Number LocalPhoneNumber	656-2423
CY2023	dei	Security12b Title Security12bTitle	Common stock
CY2023	dei	Trading Symbol TradingSymbol	WTER
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10395805	shares
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1531062	usd
CY2023Q1	wter	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	122114	usd
CY2022Q1	wter	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	187545	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108181	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5193706	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	108180	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1531062	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.73
CY2023	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredForfeitedWeightedAverageRemainingContractualTerm	P8Y6M
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1531062	usd
CY2021Q2	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	85185	shares
CY2021Q2	wter	Payment Of Exercise Price Of Warrant PaymentOfExercisePriceOfWarrant	652777	usd
CY2021Q3	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	634892	shares
CY2021Q3	wter	Payment Of Exercise Price Of Warrant PaymentOfExercisePriceOfWarrant	11904220	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6067	shares
CY2023	us-gaap	Depreciation Depreciation	900140	usd
CY2022	us-gaap	Depreciation Depreciation	801395	usd
CY2022	wter	Machinery And Equipment Reduction MachineryAndEquipmentReduction	1000000	usd
CY2023	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	The principal amount of the Revolving Facility outstanding bears interest at a rate per annum equal to (i) a fluctuating interest rate per annum equal at all times to the rate of interest announced, from time to time, within Wells Fargo Bank at its principal office in San Francisco as its "prime rate," plus (ii) 3.25%, payable monthly in arrears. The interest rate as of March 31, 2023 was 16.25%
CY2021Q2	wter	Aggregate Cash Payments AggregateCashPayments	3000000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	7913	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3667	shares
CY2021Q3	wter	Stock Issued During Period Shares Stock Options Exercised Under Cashless Exercise Plan StockIssuedDuringPeriodSharesStockOptionsExercisedUnderCashlessExercisePlan	59950	usd
CY2022Q1	wter	Stock Issued During Period Shares Stock Options Exercised Under Cashless Exercise Plan StockIssuedDuringPeriodSharesStockOptionsExercisedUnderCashlessExercisePlan	108	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2267	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.95
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	25.95
CY2022	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P9Y4M24D
CY2023Q1	wter	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	15.5
CY2022	wter	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	17.55
CY2022	wter	Class Of Warrant Or Right Forfeitures And Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4090714	shares
CY2022Q1	wter	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	18.75
CY2023	wter	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	10959354	shares
CY2023	wter	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	6.47
CY2023	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	12745068	shares
CY2023	wter	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	6.65
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21900000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21900000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2020Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10083	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	33675141	usd
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-492308	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	13390313	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1255000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	470000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3661144	usd
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.00083	pure
CY2023	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0035	pure
CY2023	wter	Line Of Credit Facility Termination Fee LineOfCreditFacilityTerminationFee	0.01	pure
CY2023	wter	Line Of Credit Facility Interest Increase Upon Default LineOfCreditFacilityInterestIncreaseUponDefault	0.05	pure
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4521085	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3620945	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2058132	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1200797	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2928085	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	417304	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.45
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.3
CY2022	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P7Y4M24D
CY2022Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1200797	usd
CY2023Q1	wter	Operating Lease Right Of Use Asset Non Current OperatingLeaseRightOfUseAssetNonCurrent	20246	usd
CY2022Q1	us-gaap	Assets Assets	22500577	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10441879	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10005	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	7371	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131805916	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	109967281	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137078578	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109515580	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5336728	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	401138	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18030103	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22500577	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	11013986	usd
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	246710	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	700000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16300000	usd
CY2023	wter	Percentage Of Limitation Of Tax Deduction For Net Operating Losses PercentageOfLimitationOfTaxDeductionForNetOperatingLosses	0.80	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5.7	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2023	us-gaap	Revenues Revenues	63777289	usd
CY2022	us-gaap	Revenues Revenues	54771942	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11015173	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21580739	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	48392577	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-22029014	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-38997910	usd
CY2023	us-gaap	Interest Expense InterestExpense	2970567	usd
CY2022	us-gaap	Interest Expense InterestExpense	917001	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5376179	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-586450	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-27405193	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-39584360	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9162239	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6608310	shares
CY2023	us-gaap	Depreciation Depreciation	900140	usd
CY2022	us-gaap	Depreciation Depreciation	801395	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5653544	usd
CY2022Q3	wter	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	6.9
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38754
CY2023	dei	Entity Registrant Name EntityRegistrantName	THE ALKALINE WATER COMPANY INC.
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	99-0367049
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Scottsdale
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	47139391.5	usd
CY2023	dei	Auditor Name AuditorName	Prager Metis CPAs, LLC
CY2023	dei	Auditor Location AuditorLocation	Basking Ridge, NJ
CY2023	dei	Auditor Firm AuditorFirmId	273
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1038754	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6520232	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7927065	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5591351	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	8583664	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2679274	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	15951725	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	21157421	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2058132	usd
CY2022Q1	wter	Operating Lease Right Of Use Asset Non Current OperatingLeaseRightOfUseAssetNonCurrent	142359	usd
CY2023Q1	us-gaap	Assets Assets	18030103	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11616247	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1996387	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2036739	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6403447	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7043870	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3192313	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2223633	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	136214	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	174565	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23344608	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	21920686	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22223	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178753	usd
CY2023Q1	us-gaap	Liabilities Liabilities	23366831	usd
CY2022Q1	us-gaap	Liabilities Liabilities	22099439	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	2827	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	4454	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13333333	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13333333	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10005379	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10005379	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7371454	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7371454	shares
CY2023Q1	us-gaap	Preferred Stock Discount On Shares PreferredStockDiscountOnShares	76898	usd
CY2022Q1	us-gaap	Preferred Stock Discount On Shares PreferredStockDiscountOnShares	0	usd
CY2022Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	62388	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52131162	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45377275	usd
CY2023	us-gaap	Gross Profit GrossProfit	11646127	usd
CY2022	us-gaap	Gross Profit GrossProfit	9394667	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22659968	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26811838	usd
CY2023	wter	Debt Conversion Expense DebtConversionExpense	2405612	usd
CY2022	wter	Debt Conversion Expense DebtConversionExpense	0	usd
CY2023	wter	Gain On Forgiveness Of Ppp Loan Payable GainOnForgivenessOfPppLoanPayable	0	usd
CY2022	wter	Gain On Forgiveness Of Ppp Loan Payable GainOnForgivenessOfPppLoanPayable	330551	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.99
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.99
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.99
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.99
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9162239	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6608310	shares
CY2022	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2227031	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5193707	usd
CY2022	wter	Stock Issued During Period Value In Connection With Convertible Note StockIssuedDuringPeriodValueInConnectionWithConvertibleNote	345455	usd
CY2022	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	1524750	usd
CY2022	wter	Stock Issued During Period Warrant Exercises StockIssuedDuringPeriodWarrantExercises	13390311	usd
CY2022	wter	Common Shares Issued To Nonemployees And Employees CommonSharesIssuedToNonemployeesAndEmployees	368419	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	5813658	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-39584360	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	401138	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	401138	usd
CY2023	wter	Stock Issued During Period Of Value Preferred Stock Series S Vesting StockIssuedDuringPeriodOfValuePreferredStockSeriesSVesting	2041445	usd
CY2023	wter	Stock Issued During Period Of Value Preferred Stock Series S Conversion To Common Stock StockIssuedDuringPeriodOfValuePreferredStockSeriesSConversionToCommonStock	0	usd
CY2023	wter	Share Issued During Period Of Value Preferred Stock Series E Conversion To Common Stock ShareIssuedDuringPeriodOfValuePreferredStockSeriesEConversionToCommonStock	1110000	usd
CY2023	wter	Stock Issued During Period Value Connection With Issuance Of Preferred Stock Series E StockIssuedDuringPeriodValueConnectionWithIssuanceOfPreferredStockSeriesE	0	usd
CY2023	wter	Preferred Stock Series E Dividend PreferredStockSeriesEDividend	12900	usd
CY2023	wter	Common Shares Issued To Nonemployees And Employees CommonSharesIssuedToNonemployeesAndEmployees	40000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1301073	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5336728	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	8409108	usd
CY2023	wter	Gain On Forgiveness Of Ppp Loan Payable GainOnForgivenessOfPppLoanPayable	0	usd
CY2022	wter	Gain On Forgiveness Of Ppp Loan Payable GainOnForgivenessOfPppLoanPayable	330551	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	271350	usd
CY2023	wter	Debt Conversion Expense DebtConversionExpense	2405612	usd
CY2022	wter	Debt Conversion Expense DebtConversionExpense	0	usd
CY2023	wter	Non Cash Interest Expense NonCashInterestExpense	47472	usd
CY2022	wter	Non Cash Interest Expense NonCashInterestExpense	24468	usd
CY2023	wter	Non Cash Lease Expense NonCashLeaseExpense	-7337	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-53252	usd
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	3192313	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3800000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1100000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Use of Estimates</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></span></span></p> </div>
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1038754	usd
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4238791	usd
CY2022Q3	wter	Number Of Common Stock Share Issue To Creditor NumberOfCommonStockShareIssueToCreditor	642241	shares
CY2022Q3	wter	Number Of Warrant Issued NumberOfWarrantIssued	825738	shares
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7775232	usd
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8397065	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6520232	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7927065	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3848750	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1930207	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4734914	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	5591351	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	8583664	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div> <p style="text-align:justify;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Property and Equipment</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company records all property and equipment at cost less accumulated depreciation. Improvements are capitalized while repairs and maintenance costs are expensed as incurred. Depreciation is calculated using the straight-line (half-life convention) method over the estimated useful life of the assets or the lease term, whichever is shorter. The Company evaluated its property and equipment for impairment and concluded for the year ended March 31, 2023, there was no impairment.</span></span></span></p> </div>
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2700000	usd
CY2023	us-gaap	Selling Expense SellingExpense	13258138	usd
CY2022	us-gaap	Selling Expense SellingExpense	13850620	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	63777289	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54771942	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="text-align:justify;margin-top:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Concentration Risks</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We have 1 major customers that account for 11% of accounts receivable at March 31, 2023, and 2 customers that together account for 35% (18% and 17%, respectively) of the total revenues earned for the year ended March 31, 2023. The Company has 3 vendors that accounted for 38% (17%, 11%, and 10% respectively) of purchases for the year ended March 31, 2023.</span></span></span></p> </div>
CY2022Q2	wter	Common Shares Sold Agent Under Sales Agreement CommonSharesSoldAgentUnderSalesAgreement	50016	shares
CY2022Q2	wter	Net Proceeds From Established Atm Facility NetProceedsFromEstablishedAtmFacility	631203	usd
CY2023	wter	Reverse Stock Split ReverseStockSplit	<div> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Reverse Stock-Split</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Effective April 5, 2023, we effected a fifteen for one reverse stock split of our authorized and issued and outstanding shares of common stock. As a result, our authorized common stock has decreased from 200,000,000 shares of common stock, with a par value of $0.001 per share, to 13,333,333 shares of common stock, with a par value of $0.001 per share, and the number of our issued and outstanding shares of common stock has decreased from approximately 152,149,661 to approximately 10,185,898. Any fractional shares resulting from the reverse stock split was rounded up to the next nearest whole number.</span></span></span></p> <p style="text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Accordingly, all share and per-share amounts for the current period and prior periods have been adjusted to reflect the reverse stock split.</span></span></span></p> </div>
CY2022	wter	Increase Decrease In Sales And Marketing Expense IncreaseDecreaseInSalesAndMarketingExpense	5824305	usd
CY2022	us-gaap	Revenues Revenues	54771942	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26811838	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	8111	shares
CY2022Q3	wter	Number Of Units Issued NumberOfUnitsIssued	9633616	shares
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137078578	usd
CY2023	us-gaap	Line Of Credit Facility Borrowing Capacity Description LineOfCreditFacilityBorrowingCapacityDescription	Under the terms of the Credit Agreement, SCM has agreed to make cash advances to our company in an aggregate principal at any one time outstanding not to exceed the lesser of (i) $10 million (the "Revolving Loan Commitment Amount") and (ii) the Borrowing Base (defined to mean, as of any date of determination, 85% of net eligible billed receivables plus 65% of eligible unbilled receivables, minus certain reserves).
CY2023Q1	wter	Line Of Credit Facility Advanced Under Credit Agreement LineOfCreditFacilityAdvancedUnderCreditAgreement	6283389	usd
CY2023Q1	wter	Aggregate Cash Payments For Fiscal Year Two AggregateCashPaymentsForFiscalYearTwo	2000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2227030	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2227030	usd
CY2023	wter	Allocated Share Based Compensation Expense Year Two AllocatedShareBasedCompensationExpenseYearTwo	2227030	usd
CY2022Q2	wter	Number Of Underwritten Public Offering Common Share NumberOfUnderwrittenPublicOfferingCommonShare	555556	shares
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4575000	usd
CY2022	wter	Common Shares Sold Agent Under Sales Agreement CommonSharesSoldAgentUnderSalesAgreement	18764	shares
CY2022Q3	wter	Warrants Deemed Price Per Shares WarrantsDeemedPricePerShares	0.37
CY2022Q3	wter	Stock Issued During Period Warrant Exercises Shares StockIssuedDuringPeriodWarrantExercisesShares	152381	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	18.75
CY2022Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	18.75
CY2023	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	6.6
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	363324	usd
CY2023Q1	us-gaap	Share Price SharePrice	4.6
CY2023Q1	us-gaap	Share Price SharePrice	500000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	10845	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	38867	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	24156	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8600	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	423415	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	282000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.41
CY2023	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P9Y6M
CY2023	wter	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P7Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	117467	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	585681	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.17
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	342828	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.77
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2021Q3	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	4757381	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	317159	shares
CY2021Q3	wter	Class Of Warrant Or Right Exercises In Period Exercise Price ClassOfWarrantOrRightExercisesInPeriodExercisePrice	18.75
CY2021Q4	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	44444	shares
CY2021Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	833334	usd
CY2022Q3	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	697290	shares
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4238791	usd
CY2022Q3	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	152381	shares
CY2022Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1051428	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60737	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	60737	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10801155	shares
CY2021Q1	wter	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	17.4
CY2022	wter	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	4757381	shares
CY2022	wter	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	18.75
CY2022	wter	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	11467822	shares
CY2022	wter	Class Of Warrant Or Right Forfeitures And Expirations In Period ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod	0	shares
CY2023	wter	Class Of Warrant Or Right Forfeitures And Expirations In Period ClassOfWarrantOrRightForfeituresAndExpirationsInPeriod	0	shares
CY2023	wter	Class Of Warrant Or Right Forfeitures And Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2305000	shares
CY2023Q1	wter	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	15.5
CY2023Q1	wter	Class Of Warrant Or Right Exercisable Number ClassOfWarrantOrRightExercisableNumber	2305000	shares
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16300000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	88000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	wter	Limitation Of Tax Deduction For Interest Expense LimitationOfTaxDeductionForInterestExpense	0.30	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2020Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5280	usd
CY2022Q2	us-gaap	Area Of Land AreaOfLand	1520
CY2022Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1812	usd
CY2022Q2	wter	Lease Rate For Extension LeaseRateForExtension	1867	usd
CY2022Q2	wter	Lease Rate For Second Extension Period LeaseRateForSecondExtensionPeriod	1923	usd
CY2023Q1	wter	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	122114	usd
CY2023Q1	wter	Operating Lease Right Of Use Asset Non Current OperatingLeaseRightOfUseAssetNonCurrent	20246	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	136214	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	141552	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23075	usd

Files In Submission

Name	View Source	Status
0001062993-23-016652-index-headers.html	Edgar Link	pending
0001062993-23-016652-index.html	Edgar Link	pending
0001062993-23-016652.txt	Edgar Link	pending
0001062993-23-016652-xbrl.zip	Edgar Link	pending
exhibit23-1.htm	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10k_htm.xml	Edgar Link	completed
wter-20230331.xsd	Edgar Link	pending
wter-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
wter-20230331_def.xml	Edgar Link	unprocessable
wter-20230331_lab.xml	Edgar Link	unprocessable
wter-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WTER
ALKALINE WATER Co INC Stock $wter

2023 Q3 Form 10-K Financial Statement

#000106299323016652 Filed on August 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTER ALKALINE WATER Co INC Stock $wter

2023 Q3 Form 10-K Financial Statement

#000106299323016652 Filed on August 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTER
ALKALINE WATER Co INC Stock $wter